Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
ALTEOGEN INC	DAEJEON 34054

International Classification(s)

• A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....
• C07K:PEPTIDES

• 2012 Application Filing Year
• A61K Class
• 11964 Applications Filed
• 9694 Patents Issued To-Date
• 81.03 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Chung, Hye-Shin	Daejeon, KR	13	95
# of filed Patents : 13 Total Citations : 95
Kim, Ji-Sun	Daejeon, KR	67	560
# of filed Patents : 67 Total Citations : 560
Lee, Sang Mee	Daejeon, KR	4	27
# of filed Patents : 4 Total Citations : 27
Park, Soon Jae	Daejeon, KR	21	105
# of filed Patents : 21 Total Citations : 105

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 1 Citation Count
• A61K Class

• 31.06 % this patent is cited more than
• 10 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Dec 9, 2026

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
June 09, 2015	US,9051395,B2   US9051395B2	GRANTED PATENT AS SECOND PUBLICATION
December 18, 2014	US,20140371160,A1   US20140371160A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent No: 9051395

Alpha-1 antitrypsin variant, preparation method thereof and use thereof

---

Abstract

---

A novel alpha-1 antitrypsin variant, a method of preparing the same, and use thereof are provided. The alpha-1 antitrypsin variant has excellent stability in the body and maintains an inhibitory effect on elastase activities because the blood half-life (t_1/2) and the area under blood drug concentration vs. time curve (AUC) are remarkably increased by adding an N-glycosylation site in animal cells through amino acid mutation between 1^st and 25^th positions of the N-terminus of alpha-1 antitrypsin. Therefore, the alpha-1 antitrypsin variant can be useful in preventing or treating alpha-1 antitrypsin deficiency.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

 

• MAFP2022
• MAFP2018
• I2015
• STCF2015
• P2014
• AS2014
• F2012
• PD2011

Date	Code	Event	Description
Nov 11, 2022	MAFP	MAINTENANCE FEE PAYMENT	free format text: PAYMENT OF MAINTENANCE FEE, 8TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2552); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY year of fee payment: 8
Nov 27, 2018	MAFP	MAINTENANCE FEE PAYMENT	free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY year of fee payment: 4
Jun 09, 2015	I	Issuance
May 20, 2015	STCF	INFORMATION ON STATUS: PATENT GRANT	free format text: PATENTED CASE
Dec 18, 2014	P	Published
Mar 10, 2014	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PARK, SOON JAE;CHUNG, HYE-SHIN;LEE, SANG MEE;AND OTHERS;REEL/FRAME:032416/0867 Owner name: ALTEOGEN, INC., KOREA, REPUBLIC OF Effective Date: Mar 10, 2014
Aug 13, 2012	F	Filing
Sep 15, 2011	PD	Priority Date